Amarin Corp Plc (AMRN)

[KCSVEN]

Option 2 is the only scenario positive for long term upside, GSK would make sense as a replacement for Lovaza, not sure they can get much, Reduce It is where it is at and BP may wait until they see if AMRN can finance to Reduce IT, if they can't buy everything even cheaper.

There is value here but BP has all the cards now. If they are lucky they can get 200 million for half of the company, only if they can get several BP's interested. I'd take it because instead of stopping Reduce IT, the whole value is in Reduce IT, if Reduce It positive sales are over 10 billion per year, thye need to do everything to get there, it fails they are done, it hits they are in major BB territory.

It's a lottery with reduce It the drawn numbers. The bog HOPE would be late 2015 interim numbers are overwhelming, if not the wait is 4 years.

At cash burn and sales growth and debt payments etc...not going to make it, going to be hard to get financing, BP is the last resort and they are there.